SEI Investments
BIVV

SEI Investments’s Bioverativ Inc. Common Stock BIVV Stock Holding History

SEI Investments’s Portfolio BIVV Stock Details BIVV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q1 		– Sell
-548,893
Closed -$29.6M – 3829
2017
Q4 		$29.6M Buy
548,893
+116,419
+27% +$6.37M 0.1% 202
2017
Q3 		$24.7M Buy
432,474
+36,650
+9% +$2.15M 0.09% 248
2017
Q2 		$23.8M Buy
395,824
+45,289
+13% +$2.58M 0.09% 242
2017
Q1 		$19.1M Buy
+350,535
New +$17.3M 0.08% 274

Other funds holding BIVV

IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
ACS
Archford Capital Strategies Swansea, Illinois $987M AUM 29.31% 1-Year Est. Return

SEI Investments's BIVV Position: Q1 2018 in Review

SEI Investments sold out of Bioverativ Inc. Common Stock (BIVV) in Q1 2018, closing a stake of 548,893 shares — an estimated $29.6M sold.

SEI Investments first reported a position in BIVV in Q1 2017 and held it in 4 quarters. The position peaked at $29.6M in Q4 2017. 2 funds tracked by Wall St. Rank hold BIVV as of Q1 2018.

  • SEI Investments reported no remaining Bioverativ Inc. Common Stock position as of Q1 2018 after selling out during the quarter.
  • SEI Investments sold 548,893 Bioverativ Inc. Common Stock shares in Q1 2018, an estimated $29.6M.
  • SEI Investments first reported a position in Bioverativ Inc. Common Stock in Q1 2017 and held it in 4 quarters.
  • SEI Investments's Bioverativ Inc. Common Stock position peaked at $29.6M in Q4 2017.
  • 2 funds tracked by Wall St. Rank held Bioverativ Inc. Common Stock as of Q1 2018.

Based on SEI Investments's 13F filing for Q1 2018, filed 11 May 2018.